Text message support for adults with sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study uses text messages to help adults with sickle cell disease learn about the latest medical guidelines and tools to manage their health. The goal is to see if this mobile approach improves how people follow their care plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been seen at the sickle cell clinic for at least the past year.
- You have been diagnosed with sickle cell disease (types SS, SC, or Sβ-thal).
- You are 18 years or older.
- You can speak and understand written English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mobile app to help people with sickle cell disease manage their health. It's designed for those who have a compatible smartphone and internet access.
This study helps connect adults with sickle cell disease who haven't seen a specialist in over a year back into care. It tests a program designed to make it easier to get regular medical support and improve your health.
This study tests a new way to screen babies for sickle cell disease at the point of care. It aims to make screening faster and easier for families and health workers.
This study tests a mobile app called Amani that helps adults with sickle cell disease manage their health. It aims to see if the app is easy to use and helpful for patients at Massachusetts General Hospital.
This study is testing a peer support program for teens and young adults (ages 16–30) with sickle cell disease who have chronic pain. You'll connect with a trained peer supporter through your smartphone to learn pain coping skills and get support.
This study collects feedback through surveys, interviews, and focus groups from people affected by sickle cell disease. Your input helps the research team improve how genomic and gene-therapy information and needs are understood for patients and caregivers.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.